Summary. The chick embryo was used to study the relationship between the onset of tumour neovascularization and tumour growth. Walker 256 carcinosarcoma was implanted on the chorioallantoic membrane (CAM) of about 600 embryos aged 5-16 days. Tumour diameter and changes in the CAM vasculature in response to the implants were recorded daily. Representative tumours were examined by light microscopy of Epon-embedded tissue and autoradiography after injection of [3H]-thymidine. Tumours remained avascular for 72 h, after which they were penetrated by new blood vessels and began a phase of rapid growth. The rate of growth during this vascular phase was greatest for implants on 5-and 6-day-old embryos and decreased the later the day of implantation.
THE GROWTH of tumours in vivo has been postulated to occur in two distinct phases (Folkman, 1974) : an initial avascular phase characterized by slow growth, during which nutrients and wastes are transported by diffusion, followed by a phase of rapid growth, in which the tumour has become vascularized. In order to study this phenomenon we employed the chorioallantois (CAM) of the developing chick embryo as a recipient of tumour grafts, and made daily observations of graft size, state of vascularity, and response of the CAM blood vessels to the growing tumour.
This study demonstrates that an avascular phase of tumour growth can be distinguished from the vascular phase by gross morphology and histology. The avascular phase is characterized by the absence of host or graft vessels within the tumour, by no visible change in the topography of the CAM blood vessels, and by slow growth for grafts less than 1 mm in diameter at implantation. The penetration of tumour by host blood vessels, followed by rapid growth, characterize the vascular phase.
MATERIALS AND METHODS
The chicken embryo hatches 21 days after fertilization. The chorioallantoic men4brane emerges on Day 4 or 5 and its vessels subsequently spread over the surface of the yolk sac, totally covering it. The fertilized white Leghorn eggs (Spafas, Norwich, Connecticut) used in this study, were kept in an egg incubator at 37°C with 60% relative humidity. Before use, the section of the shell to be opened was wiped with Betadine (providone-iodine, Purdue Frederick Co., Norwalk, Connecticut) solution and allowed to air-dry at room temperature.
Preparation of tumour implants.-Subcutaneous nodules of Walker 256 carcino-sarcoma were grown in Caesarean-derived rats by injection of cells from the ascites phase. When tumours reached 1-2 cm in diameter (approximately 5-6 days after injection), they were excised aseptically and placed in sterile lactated Ringer's solution, U.S.P. Under a dissecting microscope, pink, healthy areas of tumour were removed and cut into segments 1 x 1 x 2 mm. For a separate experiment, larger pieces up to 4 x 4 x 4 mm were used.
Tumoutr implants on the chorioallantoic membrane (Days 5 to IC' -For implantation on 5-, 6-, and 7-day CAMs, 2-3 ml of albumin was aspirated from the 5-day-old egg with a 16-g hypodermic needle through a small hole drilled at the narrow end of the egg (Zwilling, 1959) . This allowed the small CAM and yolk sac to drop away from the shell, so they would not be injured when the shell was opened. Then a 1-cm-square window was made in the eggshell on Day 5 or 6, using the false air sac technique (Hamburger, 1960 ). Eggs to be implanted after Day 8 were opened by using the false air sac technique without previous aspiration of albumin.
Each egg received a single 1 x 1 x 2-mm tumour implant which was wedged into a hole made in the CAM by a 21-g hypodermic needle. Care was taken to avoid injuring major blood vessels. The shell window was sealed with cellophane tape and eggs were replaced in the incubator. Tumour diameter was measured daily until the 18th day with a stereomicroscope containing an ocular grid (accurate to 0 1 mm) at a standard magnification of 11 x.
Grading the vascular response of the chorioallantoic membrane to tumour implants.-Changes in the pattern, density and size of the CAM blood vessels near the tumour implants were recorded daily by two different observers. This vascular response was graded as 0, 1+ or 2+, as depicted in Fig. 1 . Convergence of a few vessels toward the tumour implant was denoted as 1+, and 24+ reflected an increased density and length of vessels converging toward the tumour implant.
Representative photographs were taken of tumours implanted on 7-, 9-, and 11-day-old embryos after injecting a large CAM vein with 0*5 ml of Pelikan ink (Gunther Wagner, Hanover, W. Germany) with a 30-g hypodermic needle (Cotran, Suter and Majno, 1967) . The portion of the CAM containing the tumour was then excised, immersed in 10% formalin, and photographed while floating in a petri dish, using direct and indirect light.
Large tumour implants.-In a separate experiment, tumours 2, 3 and 4 mm in diameter were implanted on the CAM of 9-day-old chick embryos. The techniques previously described were used, except that the CAM was pierced with a No. 11 surgical blade in order to make a hole which would accommodate the implant.
Histology.-Chorioallantoic membranes containing tumour implants made between the 6th and the 11th day of embryonic life, were removed for fixation at one-day intervals from the 1st to the 10th day after implantation. The CAM was immersed for 2 h in modified Karnovsky's fixative (Karnovsky, 1965) (Baserga and Malamud, 1969) .
RESULTS
Daily measurements were made on tumours implanted on CAMs (aged 5-13 days) in a total of 632 eggs. Of these, 339 were excluded, because either the embryo did not survive for 5 or more days (86 eggs), or the grafted tumour was displaced by the moving embryo and thus failed to take (106 eggs), or the graft was not viable tumour by gross examination and confirmed by representative histologic sections (147 eggs). Tumours implanted on 14-to 16-day-old CAMs failed to incorporate into the aging membrane and fell into the allantois, leaving a hole in the membrane.
Tumour growth
All tumours implanted from Day 5 to Day 11 exhibited 2 phases of growth. During the first 72 h, tumours implanted at a size of approximately 1 mm remained near their implantation size (Fig. 2) . Thereafter, they grew rapidly. Tumours implanted on Days 12 and 13 either remained at the original implantation size for the entire observation period, or shrank after 72 h (Fig. 2) .
For the 
Large implants
Large tumours (2, 3 and 4 mm) implanted into the 9-day-old CAM, exhibited 2 distinct phases of growth (Fig. 3) Vascular response of the CAM Changes in the vasculature of the CAM in response to tumours (see Fig. 1 ) were not grossly observable until after the 10th day of incubation, regardless of the day of implantation. At this time, the membrane exhibited a positive response, i.e. a convergent set of vessels directed toward the implant. These readings are summarized in the Table. Histology A detailed histological study was carried out and has been described in a separate report (Ausprunk, Knighton and Folkman, 1975 Histologic avascular phase During the first 24 h, implants from Days 5 to 11 were incorporated into the CAM (Fig. 4) (Fig. 5) .
In tumours implanted on Day 9 or later, CAM blood vessels near the implant contained increased numbers of small (Fig. 7) . By 96 h, in implants made on 5-to 8-day CAMs, viable tumour cells and many small blood vessels were seen throughout the tumour. Seven or 8 days post-implantation, these tumours had doubled or tripled in size, although blood vessels and tumour cells at the centre of the growing implant began to degenerate. Implants made on Day 9 or later were also vascularized in 3 days. At this time, however, implants were infiltrated with chick mesodermal cells and large, debris-laden phagocytes. Thereafter tumours were gradually replaced by chick mesodermal tissue.
DISCUSSION
These experiments provide further evidence for the concept that tumour angiogenesis is a control mechanism in tumour growth. (1) Tumour growth could be divided into an initial avascular phase followed by a vascular phase. (2) Neovascularization occurred at 72 h regardless of the day of implantation. (3) Rapid growth occurred only after neovascularization, and was modulated by the age of the embryo at the time of tumour implantation.
Although previous studies (Gimbrone et al., 1972; Folkman, Cole and Zimmerman, 1972; Folkman and Hochberg, 1973) have shown that tumours maintained in the avascular state will form dormant spheroids or ellipsoids, and not enlarge beyond approximately 1 mm, each of these experiments was subject to the criticism that the tumour was either suspended in a moving fluid far from host vessels, or apposed to vessels incapable of proliferation. We now show that tumour implants completely surrounded by healthy vessels still do not grow until penetrated by new vessels. Furthermore, this is the first documentation of the time of onset of the vascular phase and its early events in the chick embryo. Even though this period is brief, i.e. 72 h, the behaviour of the tumours, histologically and grossly, are similar to avascular spheroidal tumour growth in three previous reports. Thus, in the avascular phase, tumours appeared spheroidal. They did not spread out as flat plates along the CAM. The size of the tumour at the end of the avascular phase was relatively constant (about 1 mm). These tumours consisted of a population of centrally necrotic cells, together with proliferating cells at the periphery. Tumour implants 2 mm and larger shrank rapidly during the avascular phase, but were 1 4-2*5 mm at 72 h when vascular penetration occurred. Thus, the behaviour of implants during the avascular period in vivo resembled the growth of tumours in vitro, where transport of nutrients and wastes occurs only by diffusion (Folkman, Hochberg and Knighton, 1974) .
During the 72-h avascular phase, rat blood vessels within the tumour transplants disintegrated by approximately 24 h (Ausprunk and Folkman, 1976) . A number ofevents probably occurwhichlead to the penetration of the tumour by new host vessels. These include the envelopment of the tumour by the host membrane, production of an angiogenic factor (TAF) by the tumour, the endothelial cell response to TAF and the formation of new capillaries which travel toward the centre of the tumour. The time of onset of the vascular phase seemed to be independent of the immunological status of the embryo. Thymus cells are present by Day 11, and cell-mediated immunity has been demonstrated by Day [13] [14] (Solomon, 1971 ). However, the onset of angiogenesis occurred after 72 h regardless of the day of implantation.
The vascular phase was marked by three significant events. The first was the rapid tumour growth which began between 72 and 96 h (Fig. 3) . The second was the disappearance of the central necrosis which had been present in the previous avascular phase. As tumours approached 3-4 mm, central necrosis reappeared, probably because the deeper vessels were compressed by the expanding tumour mass (Goldacre and Sylven, 1959; Young, Lumsden and Stalker, 1950) . The third was a gradual decrease in the slopes of the tumour growth curves as the age of the implanted embryo increased. The gradual decrease in the rate of tumour growth as a function of the day of implantation may be related to the immunological state of the embryo. The presence of monocytic cells at the periphery of tumours implanted after Day 9 supports this possibility. The onset of immunity could modify the rate of tumour growth, while at the same time the beginning of rapid growth is determined by the penetration of new vessels. These two phenomena, angiogenesis and immunity, may operate independently in their effects upon tumour growth.
An alternative explanation is that as the CAM ages or matures, the growth of the tumour might slow down, due to a decrease in the amount of blood being supplied to the CAM. The CAM does begin to degenerate between Days 17 and 19 (Zwilling, 1959; Hamburger, 1960) , but this would seem to occur too late to account for the steadily decreasing rate of tumour growth observed for implants from Day 5 to 13.
A separate study of the normal mitotic activity of the CAM endothelium, made in our laboratory (Ausprunk, Knighton and Folkman, 1974) , could explain why a membrane response to implanted tumours is not grossly observable until after the 10th or 11th day of incubation. The-CAM endothelium exhibits an intrinsically high mitotic rate (thymidine labelling index of 23% for 5-h thymidine exposure) until Day 10. At the 11th day of incubation this labelling index falls to 2% and remains low throughout the remaining incubation period. Thus any angiogenic stimulus might be masked by the normally high background activity of growing vessels, up to the 11th day. After this, when vessel growth slows down, the altered pattern of the CAM vessels in response to an angiogenic factor might be more easily detected. This capacity of the CAM to display a vascular response after 11 days permits us to use it as an assay for TAF fractions.
Finally, although there are many reports on the use of the chick CAM for tumour growth, this is the first study in which the parameters of tumour growth have been quantitated over such a wide range of implantation times, i.e. througlhout almost the entire incubation period of the chick embryo. This will provide a standard of comparison for future studies of the effects of angiogenesis, immunity, tolerance, radiation, and implant size, on tumour growth. These data should also provide a standard for future studies of possible inhibitors of tumour angiogenesis.
We thank Dr Robert Auerbach and Dr Ramzi S. Cotran for helpful advice, Mrs Gwladys Caspar for technical assistance, Ms Christine Keller for histological assistance, Mr Janis Cirulis for medical art, and Mrs Pauline Breen for typing the manuscript.
This work was supported by a grant from the National Cancer Institute (No. IROl-CA 14019-01), a grant from the American Cancer Society (No. DT-2A), and gifts from Alza Corporation, Merck Co., and Mr Morton Bank.
